Chronic hepatitis B
Chronic hepatitis B is a common type of hepatitis B. Hepatitis B is characterized by a slow onset, with subclinical and chronic types being more common. Acute non-icteric HBsAg-positive patients are prone to chronic disease. The course of chronic hepatitis often exceeds half a year, and the disease can develop insidiously, often discovered during physical examinations. The symptoms vary, with recurrent attacks or prolonged illness. An estimated 5% to 10% of patients with acute hepatitis B develop into chronic hepatitis. The chronicity of acute hepatitis B depends mainly on the age of initial infection, immune status, and viral levels. Infections in infancy and childhood are prone to chronic disease. Patients using immunosuppressants and cytotoxic drugs, and patients with chronic renal failure on hemodialysis often lack obvious acute phase manifestations and have a protracted illness. Patients with very high serum levels of viral replication markers (HBeAg, HBV DNA) are more likely to develop chronic hepatitis.
Related Drugs
Telbivudine Tablets
Indication: 1. Telbivudine is used for adult patients with chronic hepatitis B with evidence of viral replication and persistent elevation of serum aminotransferase (ALT or AST) or evidence of active liver tissue lesions. 2. This indication is based on the virological, serological, biochemical and histological response results of adult patients with chronic hepatitis B who are HBeAg-positive and HBeAg-negative and have compensated liver function who are naive to nucleoside analogs. The effect of telbivudine has not been evaluated in hepatitis B patients with concurrent HIV, HCV or HDV infection. The effect of telbivudine has not been evaluated in liver transplant patients or patients with decompensated liver disease. There are no well-designed controlled studies using telbivudine in patients with chronic hepatitis B who are resistant to nucleoside analog reverse transcriptase inhibitors, but it is estimated that it may have cross-resistance with lamivudine.
Manufacturer:
Viatris Pharmaceuticals (DALIAN) Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Changshu Leiyunshang Pharmaceutical Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Furen Pharmaceutical Group Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Hunan Wzt Pharmaceutical Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Competent Investments Limited
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Jiangsu Suzhong Pharmaceutical Group Biopharmaceutical Co., Ltd.
Adefovir Dipivoxil Tablets
Indication: This product is suitable for the treatment of adult patients with chronic hepatitis B with active replication of hepatitis B virus and compensated liver function with persistent elevation of serum amino acid transferase.
Adefovir Dipivoxil Capsules
Indication: This product is suitable for the treatment of adult patients with chronic hepatitis B who have evidence of active replication of hepatitis B virus and compensated liver function with persistent elevation of serum amino acid transferase (ALT or AST) or active liver histological lesions.
Manufacturer:
CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.